GlyTech
About:
GlyTech is a responsibility of the company to protect personal information in its business activities.
Website: https://www.glytech.jp/jp/
Top Investors: Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, SBI Investment, DBJ Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)
Description:
GlyTech is focused on the application of glycan production and chemical glycosylation technologies to the development of innovative and improved medicines such as biopharmaceuticals and oligonucleotide therapeutics.
Total Funding Amount:
2.26B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Kyoto, Kyoto, Japan
Founded Date:
2012-04-02
Founders:
Asai Hiroaki
Number of Employees:
11-50
Last Funding Date:
2020-07-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai